Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03B/oil-in-water emulsion-adjuvanted (AS03B) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age

Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03B/oil-in-water emulsion-adjuvanted (AS03B) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age

Bibliographic Details
Main Authors: CS Waddington, N Andrews, K Hoschler, WT Walker, C Oeser, A Reiner, T John, S Wilkins, M Casey, PE Eccleston, RJ Allen, I Okike, S Ladhani, E Sheasby, P Waight, AC Collinson, PT Heath, A Finn, SN Faust, MD Snape, E Miller, AJ Pollard
Format: Article
Language:English
Published: NIHR Journals Library 2010-10-01
Series:Health Technology Assessment
Online Access:https://doi.org/10.3310/hta14460-01

Internet

https://doi.org/10.3310/hta14460-01

Similar Items